乙型肝炎病毒感染与肝外表现:一种系统性疾病
本文综述了慢性乙型肝炎病毒(HBV)感染相关的肝外表现,包括系统性血管炎、肾小球肾炎、皮肤表现、血液系统恶性肿瘤和神经系统疾病等,这些表现与显著发病率和死亡率相关,机制涉及HBV诱导的局部和全身炎症,抑制HBV复制通常可改善肝外表现。
要点
- 慢性HBV感染除肝脏并发症外,肝外表现长期被低估。
- 已描述的肝外综合征包括系统性血管炎、肾小球肾炎和皮肤表现。
- 新近描述的肝外表现包括血液系统恶性肿瘤和神经系统疾病。
核心结论
- HBV感染是一种系统性疾病,肝外表现与显著发病率和死亡率相关。
- 抑制HBV复制通常可改善肝外表现。
研究设计与样本
- 综述,讨论HBV如何诱导炎症及HBV感染的肝外表现以指导临床管理。
主要发现
- 慢性HBV感染者面临包括终末期肝病和肝细胞癌在内的肝脏并发症高风险。
- 已充分描述的肝外综合征包括系统性血管炎、肾小球肾炎和皮肤表现。
- 新近描述的肝外表现包括血液系统恶性肿瘤和神经系统疾病。
- 肝外表现的发生机制尚未完全明了,但包括HBV诱导的局部和全身炎症。
临床怎么用
- 抑制HBV复制通常可改善肝外表现。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
People living with hepatitis B virus (HBV) chronic infection are exposed to high rates of liver complications including end-stage liver disease and hepatocellular carcinoma. Extrahepatic manifestations of HBV infection have long been underestimated. Several of these extrahepatic syndromes have been well described, including systemic vasculitides, glomerulonephritis, and cutaneous manifestations. Other manifestations have been more recently described such as hematological malignancies and neurological diseases. These extrahepatic manifestations are associated with significant morbidity and mortality. Although not completely understood, underlying mechanisms include HBV-induced local and systemic inflammation. Suppression of HBV replication usually improves extrahepatic manifestations. This review will discuss how HBV induces inflammation and the extrahepatic manifestations of HBV infection to guide clinical management.
引用
- Cacoub P, Asselah T. Hepatitis B Virus Infection and Extra-Hepatic Manifestations: A Systemic Disease. Am J Gastroenterol. 2022. PMID: 34913875. doi:10.14309/ajg.0000000000001575
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。